A phase 1b/2 study of ARRY-382, an oral inhibitor of colony stimulating factor 1 receptor (CSF1R), in combination with pembrolizumab (Pembro) for the treatment of patients (Pts) with advanced solid tumors.

被引：9

作者：

Harb, Wael A.

Johnson, Melissa Lynne

Goldman, Jonathan Wade

Weise, Amy M.

Call, Justin Anthony

Dudek, Arkadiusz Z.

Gonzalez, Rene

Cowey, C. Lance

Eves, P. Taylor

Gollerkeri, Ashwin

Gainor, Justin F.

机构：

来源：

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.TPS3110

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS3110

引用

页数：5